(原标题:童颜针没有护城河:围猎圣博玛的,不只有新氧)导语:获批上市的同类产品已有9款,另有十多家正在排队申报的童颜针。再加上有相似功效的3款产品,竞争已趋白热化。“九狼”围城童颜针阵营持续扩容。7月11日,康哲药业独家代理的西宏医药的丽真然,与上海爱唯缇代理的Olidia,分别获得了国家药品监督局批准。这波新玩家的涌入,将本就激烈的市场竞争推向了新高度。对国内首款获批的童颜针——艾维岚而言,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.